Contact lens consolidation
This article was originally published in The Gray Sheet
Executive Summary
Essilor subsidiary BBGR has signed an agreement to make an outright purchase of all Rupp & Hubrach capital. Rupp & Hubrach, which is BBGR's German ocular products distributor, is Germany's fifth-ranked corrective lens manufacturer, generating approximately $54 mil. in revenue last year, according to BBGR. France-based Essilor is owned by Ocular Sciences (1"The Gray Sheet" Feb. 19, 2001, p. 16)...
You may also be interested in...
Ocular Sciences Gains Direct European Lens Marketing Presence Via Essilor
Ocular Sciences' $47 mil. acquisition of the contact lens business of Paris-based Essilor International adds a direct European sales force of approximately 50 reps and provides an expedited entry into the specialty lens market.
Dr Reddy’s Knocked Back On Rituximab In US
Dr Reddy’s has received a complete response letter from the US FDA, knocking back its proposed rituximab biosimilar rival to Rituxan.
Sandoz And Samsung Celebrate Stelara Rival’s EU Approval
Sandoz and Samsung Bioepis have received final European Commission approval for their partnered Pyzchiva biosimilar rival to Stelara. But with European competition on ustekinumab due to kick off in just a matter of months, further applicants are also waiting in the wings.